Viz HCM vs Merlin.net

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Abbott (formerly St. Jude Medical)

AI Verdict

Viz HCM focuses on the early detection of Hypertrophic Cardiomyopathy using real-time ECG analysis and coordinating care for newly diagnosed patients. In contrast, Merlin.net is designed for the remote monitoring and management of patients who already have Abbott implanted cardiac devices. While both tools leverage AI in cardiology, Viz HCM aids in diagnosis and initial care coordination, whereas Merlin.net supports ongoing post-implantation patient management.

Choose Viz HCM if…

Choose Viz HCM if your primary objective is to leverage AI for real-time, rapid detection of suspected Hypertrophic Cardiomyopathy (HCM) directly from ECGs within an acute care or hospital setting. This tool is ideal for institutions focused on significantly reducing diagnosis time and automating immediate care coordination for a specific, often underdiagnosed, cardiac condition.

View Viz HCM →

Choose Merlin.net if…

Choose Merlin.net if you require a comprehensive, web-based platform for the remote monitoring and long-term management of patients with Abbott implanted cardiac devices. This tool is best suited for cardiology practices and clinics focused on efficient remote follow-up, proactive device performance tracking, and streamlined data management for their existing patient population with pacemakers, ICDs, or other Abbott cardiac implants.

View Merlin.net →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz HCM Merlin.net
Deployment Unknown Web-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

Viz HCM offers mobile-based alerts and notifications to multidisciplinary care teams, which is crucial for real-time disease detection and rapid care coordination in acute settings. Its focus on streamlining workflows to reduce diagnosis time suggests a highly optimized and intuitive user experience for a critical use case. Merlin.net, while comprehensive, is a web-based platform for managing existing device patients, which is a different operational context.

Clinical Value

Viz HCM

Viz HCM is an FDA-cleared AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy, significantly reducing diagnosis time and coordinating care. This direct impact on early diagnosis and treatment initiation for a life-threatening condition, backed by clinical validation, offers a higher immediate clinical value. Merlin.net focuses on remote monitoring of implanted devices, which is valuable for ongoing management but not for initial disease detection and rapid intervention.

Pricing & Value

Viz HCM

Viz HCM provides transparency with its subscription-based pricing and, importantly, highlights CMS reimbursement availability for specific CPT codes, offering a clear financial value proposition for healthcare systems. Merlin.net's pricing is listed as 'contact vendor for pricing,' which lacks the same level of transparency regarding cost and potential reimbursement pathways.

Enterprise Readiness

Viz HCM

Both tools are cloud-based, HIPAA compliant, have BAA, and integrate with EHRs. However, Viz HCM's broader application of AI-powered ECG analysis for HCM detection across any patient presenting with an ECG makes it more generally applicable across a hospital enterprise. Merlin.net, while robust, is specifically designed for managing Abbott implanted cardiac devices, which might limit its scope to facilities utilizing those particular devices.

Innovation

Viz HCM

Viz HCM demonstrates higher innovation by leveraging AI for real-time ECG analysis to detect a specific, often underdiagnosed condition and then automating care coordination. This application of AI to streamline acute clinical workflows for disease detection is more novel. Merlin.net, while offering comprehensive remote monitoring features, operates within the more established domain of implanted cardiac device management.

Support & Docs

Tie

Both Viz.ai and Abbott are established companies in the healthcare technology and medical device sectors, respectively. Viz.ai offers 24/7 urgent phone support and a help center with troubleshooting and user guides. Abbott's Merlin.net provides detailed manuals, resources, and education & training for healthcare professionals. Without more specific comparative details on the depth, breadth, and responsiveness of their support and documentation, it is difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz HCM Merlin.net
Name Viz HCM Merlin.net
Company Viz.ai Abbott
Primary Function AI-powered ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. Web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.
Integration Capabilities Seamless integration with existing clinical workflows, EHR, and PACS systems. EHRDirectu2122 data transfer for seamless EHR integration (HL7 standards).
Target Specialties Cardiology, Emergency Medicine, Hospital Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring Viz HCM and Merlin.net.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz HCM is an AI tool designed for real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, aiming to reduce diagnosis time. Merlin.net is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up and device performance monitoring.
Viz HCM is intended for patients aged 18 years or older with 12-lead ECG recordings, specifically to detect signs associated with hypertrophic cardiomyopathy. Merlin.net is designed for patients with Abbott implanted cardiac devices, such as pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices, to facilitate remote management.
Viz HCM is a cloud-based platform that integrates into hospital IT systems, including EHR and PACS, to streamline cardiac care coordination and clinical workflows. Merlin.net offers EHRDirectu2122 data transfer for seamless EHR integration, supporting HL7 standards, and is compatible with various EHR systems.
Viz HCM has CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90, effective January 1, 2025. For Merlin.net, pricing information requires contacting the vendor, and while remote monitoring often has specific codes, the provided information does not detail specific reimbursement codes for its use.
Viz HCM utilizes real-time analysis of 12-lead electrocardiograms (ECGs) to detect suspected Hypertrophic Cardiomyopathy. Merlin.net imports and manages cardiac information and data directly from Abbott implanted cardiac devices.
Viz HCM is suitable for Cardiology, Emergency Medicine, and Hospital Medicine, given its focus on early detection and care coordination for HCM. Merlin.net is primarily designed for Cardiology, supporting the remote management of patients with implanted cardiac devices.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.